Quetiapine for the treatment of alcoholism: Scientific rationale and review of the literature
Authors:
- 19 August 2010
- journal article
- review article
- Published by Wiley in Drug and Alcohol Review
- Vol. 29 (5) , 568-575
Abstract
Issues. The development of effective treatments for alcohol use disorders represents an important public health concern. Quetiapine, a multiple receptor antagonist at 5‐HT1Aand 5‐HT2A, dopamine D1and D2, histamine H1, and adrenergic α1and α2receptors, is an atypical antipsychotic medication that has recently shown promise for the treatment of alcoholism.Approach. This manuscript reviews the rationale and empirical literature suggesting that quetiapine may be useful for the treatment of alcohol use disorders, including a discussion of its putative neurobiological and biobehavioural mechanisms of action.Key Findings. The effects of quetiapine on drinking outcomes may be due to its effects on mood, anxiety and sleep, which may help alleviate protracted withdrawal symptoms and address psychiatric comorbidities often associated with alcohol use disorders.Implications. These findings have implications to treatment development for alcoholism and suggest that the scientific study of quetiapine for alcoholism warrants further resources and attention.Conclusion. Quetiapine has advanced as a potentially promising pharmacotherapy for alcoholism. Additional research is needed to more clearly ascertain its clinical utility as a stand‐alone treatment for this indication, as well as to identify patients who are more likely to respond favourably to this medication.[Ray LA, Heydari A, Zorick T. Quetiapine for the treatment of alcoholism: Scientific rationale and review of the literature.Drug Alcohol Rev2010]Keywords
This publication has 69 references indexed in Scilit:
- Extrapyramidal side-effects of antipsychotics in a randomised trialThe British Journal of Psychiatry, 2008
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- A Double-Blind, Placebo-Controlled Pilot Trial of Quetiapine for the Treatment of Type A and Type B AlcoholismJournal of Clinical Psychopharmacology, 2007
- Additional Evidence of the Abuse Potential of QuetiapineSouthern Medical Journal, 2007
- Intravenous Quetiapine-Cocaine Use ("Q-Ball")American Journal of Psychiatry, 2007
- Perception of Sleep in Recovering Alcohol‐Dependent Patients With Insomnia: Relationship With Future DrinkingAlcohol, Clinical and Experimental Research, 2006
- Intravenous Quetiapine AbuseAmerican Journal of Psychiatry, 2005
- Intranasal Quetiapine AbuseAmerican Journal of Psychiatry, 2004
- The Efficacy of Acamprosate in the Maintenance of Abstinence in Alcohol‐Dependent Individuals: Results of a Meta‐AnalysisAlcohol, Clinical and Experimental Research, 2004
- Clinical Pharmacokinetics of QuetiapineClinical Pharmacokinetics, 2001